Navigation Links
Ventria Receives Friends of Education Award From Geary County School District
Date:3/4/2008

JUNCTION CITY, Kan., March 4 /PRNewswire/ -- Yesterday Ventria Bioscience received the Friends of Education Award from the Geary County School District Board. Ventria received the award for their commitment to providing unique educational opportunities in biotechnology for students and teachers. Ventria has provided students with opportunities for job shadowing and internships in biotechnology. In 2007, Ventria provided a grant for a teacher from Junction City High School to attend the Biotechnology Institute's Teacher-Leader program and provided a guided tour of their bioprocessing facility for the Junction City High School Science Department Faculty.

"As a new business in Junction City, Ventria Bioscience quickly demonstrated itself to be a corporate citizen committed to supporting public education. The company has become a tremendous asset for USD 475 and Junction City High School. The Geary County Schools and the Junction City Education Association are most pleased to recognize and honor Ventria with a Friends of Education Certificate of Award from the Confidence in Kansas Public Education Task Force," said Charles Volland, district communications coordinator.

"Education is the foundation of future progress for society. Ventria is pleased to be able to contribute to educational opportunities for students and teachers in Junction City by supporting teacher training programs and offering student job shadowing and internships. We hope to inspire local students to see what is possible and become the next generation of scientists leading to a better tomorrow," said Greg Unruh, Vice President and General Manager, Ventria Bioscience.

About Ventria Bioscience

Ventria is committed to developing affordable human health products that enhance and save lives. A recent child health study showed that Ventria's product helped reduce the duration of diarrhea in children by 30 percent. Childhood diarrhea is the second leading killer of children, claiming 2 million lives annually according to the World Health Organization. For more information, visit http://www.Ventria.com.

About the Geary County Unified School District

Geary County School District No. 475 operates the public schools in Junction City, Fort Riley, Milford and Grandview Plaza. The district serves approximately 6,400 students representing a cross-section of socioeconomic and ethnic groups. Approximately 50 percent of the district's students have a parent or guardian on active duty with the U.S. Army at Fort Riley, Kansas. The district operates 13 elementary schools, two middle schools and one high school.

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.


'/>"/>
SOURCE Ventria Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Science Teachers Tour Ventrias Bioprocessing Facility
2. Ventria Expands Team and Hires Kansan as Director of Bioprocessing Operations
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
7. IsoTis Receives FDA Clearance for Accell Family of Products
8. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
9. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
10. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
11. XTL Receives Staff Letter From NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
(Date:2/22/2017)... ... 2017 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), a ... announced it has issued a scientific white paper entitled “Results from recent Alzheimer’s ... commentaries from ProMIS’s scientific team offering insight into the Company’s product portfolio and ...
(Date:2/22/2017)... 22, 2017 Origin (Origin Agritech, LLC, a subsidiary of ... provider, and Arcadia (Arcadia Biosciences, Inc., NASDAQ: ... commercializes agricultural productivity traits and nutritional products, today announced their collaboration ... developed in China to the ... ...
Breaking Biology Technology:
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):